Search

Your search keyword '"Susan K. Gilmour"' showing total 69 results

Search Constraints

Start Over You searched for: Author "Susan K. Gilmour" Remove constraint Author: "Susan K. Gilmour"
69 results on '"Susan K. Gilmour"'

Search Results

1. Loss of Anti-Tumor Efficacy by Polyamine Blocking Therapy in GCN2 Null Mice

2. Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells

Catalog

Books, media, physical & digital resources

3. A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors

4. Immunomodulatory role of thrombin in cancer progression

7. Data from Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment

10. Supplementary Data (for publication) from Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

11. Data from Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

12. Data from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

13. Data from Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase

14. Supplementary Figure 3 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

15. Supplementary Figure 1 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

16. Supplementary Figure Legends 1-3 from ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

18. Harnessing the polyamine transport system to treat BRAF inhibitor-resistant melanoma

19. Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade

20. A novel polyamine blockade therapy activates an anti-tumor immune response

21. Polyamine-stimulation of arsenic-transformed keratinocytes

22. Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment

23. Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine

24. Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis

25. Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion

26. ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

27. Polyamines and nonmelanoma skin cancer

28. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

29. Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase

30. A Novel Protein Kinase CK2 Substrate Indicates CK2 Is Not Directly Stimulated by Polyamines in Vivo

31. 1-Methyl-Tryptophan Synergizes with Methotrexate to Alleviate Arthritis in a Mouse Model of Arthritis

32. Polyamines regulate gap junction communication in connexin 43-expressing cells

33. K6/ODC transgenic mice as a sensitive model for carcinogen identification

34. High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation

35. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin

36. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells

37. Development of polyamine transport ligands with improved metabolic stability and selectivity against specific human cancers

38. Elevated Cellular Polyamine Levels Enhance Promoter Activityin Vivo

39. Myo/Nog Cells in Normal, Wounded and Tumor Bearing Skin

40. A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development

41. Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate

42. Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes

43. Polyamine-mediated regulation of protein acetylation in murine skin and tumors

44. Abstract 392: Synergistic anti-tumor effects of dabigatran etexilate and cyclophosphamide co-treatment are associated with decreased circulating tissue factor positive microparticles

45. Role of Polyamines in the Regulation of Chromatin Acetylation

46. B23 is a downstream target of polyamine-modulated CK2

47. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells

48. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice

49. Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation

50. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors